Healthcare teams should first identify where patient data and connected devices are exposed across portals, telehealth workflows, and medical equipment. From there, they can prioritise certificate-backed authentication and encryption for the highest-risk connections. The goal is to establish trusted device and user identity before expanding into broader governance, monitoring, and lifecycle controls.
Why exposure mapping comes before control selection
For telehealth and connected devices, the first job is to find where protected data and device traffic actually cross trust boundaries. That means mapping patient portals, clinician workflows, remote access paths, device management channels, and any integrations that move data between systems before deciding which controls to add. Without that inventory, teams tend to harden the wrong links first.
In practice, the highest-value finding is usually not a missing tool, but an undocumented path: a vendor portal that reaches clinical systems, a device console that accepts weak trust assumptions, or a workflow that reuses a credentialed session across systems. Those are the places where authentication and encryption will deliver the biggest reduction in exposure.
Why certificate-backed trust matters in this environment
Once the exposed connections are known, the most important early control is to establish device and user trust with certificate-backed authentication and encryption for the most sensitive paths. Telehealth and medical-device environments often span networks, vendors, and managed services, so the question is not whether encryption exists somewhere, but whether the right connection is authenticated end-to-end and protected from interception or impersonation.
This is especially important when the environment includes devices that cannot tolerate frequent manual intervention, because weaker trust mechanisms tend to persist longer than they should. Strong certificates, mutual verification, and encrypted channels reduce the chance that a remote session, device command, or data exchange is accepted from an untrusted source.
How to sequence the wider security programme after the first pass
After exposure mapping and trusted connection setup, the broader programme should extend to governance, monitoring, and lifecycle control. That sequence matters because it is easier to govern a trusted set of portals, devices, and integrations than to retrofit control over an environment whose trust boundaries are still unclear. The early objective is to make the highest-risk interactions explicit and defensible.
From there, teams can classify which workflows need stronger monitoring, which devices need tighter access review, and which connections require recurring certificate renewal or decommissioning rules. In healthcare settings, the practical risk is not only compromise, but stale trust that survives long after a device, user, or integration has changed role.
Risk and Threat Considerations
Telehealth and connected devices expand the attack surface because they combine remote access, patient data, and operational technology-like constraints. If teams modernise controls without first identifying exposed pathways, they can leave high-value traffic vulnerable to interception, misuse, or trust abuse even while the rest of the programme looks improved.
Failure mechanism: Hidden portals, unmanaged integrations, or device channels keep accepting traffic without strong authentication or encryption, which allows an attacker or misconfigured system to reuse trust where it should have been bounded.
Impact: Patient data exposure, device manipulation risk, and weak auditability can follow, especially where remote workflows or third-party systems extend the blast radius beyond the original system owner.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST SP 800-53 Rev 5 and CIS Controls v8 set the technical controls, while ISO/IEC 27001:2022 and SOC 2 (AICPA) define the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST SP 800-53 Rev 5 | IA-2 — Identification and Authentication (Organizational Users) | Telehealth portals and clinician access depend on strong user authentication. |
| IA-9 — Identification and Authentication (Non-Organizational Users) | Patient-facing telehealth access often includes external users and remote participants. | |
| IA-5 — Authenticator Management | Certificate-backed trust depends on secure lifecycle management of authenticators and credentials. | |
| Recommendation — Require strong user authentication for clinician and staff access to telehealth systems. Use strong authentication controls for patient and external telehealth access. Manage certificates and other authenticators with defined issuance, rotation, and revocation rules. | ||
| ISO/IEC 27001:2022 | A.5.9 — Inventory of information and other associated assets | You must identify exposed portals, workflows, and devices before hardening them. |
| A.8.24 — Use of cryptography | Certificate-backed authentication and encryption are central to the control sequence here. | |
| A.8.20 — Network security | Remote healthcare workflows depend on secure network paths and boundary control. | |
| Recommendation — Maintain an accurate inventory of telehealth systems and connected devices. Apply cryptography to protect telehealth data in transit and validate trust relationships. Harden network paths that carry telehealth and medical-device traffic. | ||
| CIS Controls v8 | CIS-1 — Inventory and Control of Enterprise Assets | Exposure cannot be prioritised until portals and connected devices are identified. |
| CIS-6 — Access Control Management | The answer prioritises trusted device and user identity before broader governance. | |
| CIS-12 — Network Infrastructure Management | Securing the highest-risk connections is part of protecting telehealth transport paths. | |
| Recommendation — Inventory assets that participate in telehealth and medical-device workflows. Restrict and review access to telehealth portals and connected devices. Protect the network paths that carry remote care and device traffic. | ||
| SOC 2 (AICPA) | CC6.1 — Logical and Physical Access Controls | Telehealth trust depends on controlling who and what can access patient systems. |
| Recommendation — Restrict logical access to telehealth and connected-device systems. | ||
Practitioner Guidance
What to prioritise: Start with the connections that can move patient data into or out of clinical systems, then rank them by whether they expose a live device, a privileged workflow, or a vendor-managed path. Those are the links most likely to justify immediate certificate-based hardening.
What to verify: Confirm that the trust decision is bound to the connection itself, not just to the user interface or network segment. If a session can reach a device, portal, or clinical workflow without strong mutual verification, it is not yet a safe foundation for broader expansion.
Practitioner takeaway: In this kind of modernisation, identity and encryption are first-order controls only after exposure is mapped, because the main failure mode is not missing governance, but trusting the wrong connections too early.
Related resources from NHI Mgmt Group
- How should healthcare security teams use pentesting to reduce ransomware risk across connected systems and medical devices?
- How should healthcare security teams secure connected medical devices without disrupting clinical operations?
- How should security teams prioritise NHI remediation in cloud environments?
- How should security teams govern non-human identities at scale?
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on September 26, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
